Keyphrases
Acid Activation
100%
Carotid Artery
100%
Matricellular Proteins
100%
Neointima Formation
100%
Lysophosphatidic Acid
100%
Vascular Remodeling
20%
Extracellular Matrix Protein 1 (ECM1)
13%
Smooth muscle Cell Migration
13%
Acid Infusion
13%
Lysophosphatidic Acid Receptor
13%
Therapeutic Intervention
6%
Small Interfering RNA (siRNA)
6%
Vascular Disease
6%
Mouse Model
6%
Restenosis
6%
Receptor Function
6%
Centralized Control
6%
Receptor Knockout
6%
Vascular Smooth muscle Cell Migration
6%
In Vivo Model
6%
Disease Marker
6%
Oxidized Low-density Lipoprotein (ox-LDL)
6%
Neointimal Lesion
6%
Bioactive Components
6%
Activated Platelets
6%
Vascular Treatment
6%
Disease Potential
6%
Pharmacology, Toxicology and Pharmaceutical Science
Lysophosphatidic Acid
100%
Neointima
100%
Vascular Remodeling
20%
Matrix Protein
13%
Lysophosphatidic Acid Receptor
13%
Mouse Model
6%
Restenosis
6%
Atherosclerosis
6%
Small Interfering RNA
6%
Disease Marker
6%
Vascular Disease
6%
Oxidized Low Density Lipoprotein
6%